Skip to content

Single Versus Multiple Injections for Axillary Plexus Block

Single Versus Multiple Injections for Axillary Plexus Block: a Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03378323
Enrollment
50
Registered
2017-12-19
Start date
2018-07-01
Completion date
2019-04-10
Last updated
2019-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Extremity

Keywords

upper extremity surgery

Brief summary

Patients will be randomized to one of two groups: 1. Multiple injection group: Axillary brachial plexus block with multiple injections, with the arm abducted, performed with the aid of ultrasound; 2. Single injection group: Axillary brachial plexus block with a single injection, with the arm placed behind the head and the elbow flexed, performed with the aid of ultrasound

Detailed description

The study will be proposed to all patients undergoing formarm or hand surgery under axillary brachial plexus block. Patients will be randomized to one of two groups The first group - multiple injection group - will receive an ultrasound-guided axillary brachial plexus block with the traditional technique, i.e. multiple injections of local anesthetic in proximity to the 4 nerfs that innervate the arm. The arm will be abducted during the block procedure. The second group - single injection group - will receive an ultrasound-guided axillary brachial plexus block with the arm placed behind the head and the elbow flexed. In this position the different nerfs group around the axillary artery where they will be blocked with a single injection of local anesthetic. All patients will receive the same type and amount of local anesthetic: 30 ml of a mixture of ropivacaine 0.5 % + mepivacaine 1 %. The primary outcome measure is the time needed for the performance of the block. Secondary outcomes are: success rate of the block at 30 minutes after the injection, needling time, time to first analgesic request, postoperative opioid consumption, pain scores at 12 and 24 hours postoperatively, block-related complications, and patient satisfaction. These outcomes are further defined in the section below.

Interventions

DRUGMultiple injection local anesthetic

Multiple injection local anesthetic

DRUGSingle injection local anesthetic

Single injection local anesthetic

Sponsors

University of Lausanne Hospitals
CollaboratorOTHER
Hôpital du Valais
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients who undergo forearm or hand surgery under axillary brachial plexus block

Exclusion criteria

* History of allergic reaction to local anaesthetics * Peripheral neuropathy * Renal or hepatic insufficiency * Coagulation disorders

Design outcomes

Primary

MeasureTime frameDescription
Performance time10 minutesTime in minutes from ultrasound probe placement to end of local anesthetic injection

Secondary

MeasureTime frameDescription
Time to first analgesic request24 hoursTime in minutes to first analgesic request postoperatively
Block-related complications24 hoursInfection, bleeding, neurological problems, pain during the 24 postoperative hours
Postoperative opioid consumption on postoperative day 124 hoursintravenous morphine equivalent consumption during the 24 postoperative hours
Needling time15 minutesTime in seconds to complete the block
Pain scores on postoperative day 124 hoursMeasured on a visual analogue scale between 0 and 10 (0 = no pain, 10 = worst pain imaginable)
Patient satisfaction24 hoursAssessed by numerical rating scale on a scale between 0 (= completely dissatisfied) and 10 (= completely satisfied)
Pain scores at 12 hours postoperatively12 hoursMeasured on a visual analogue scale between 0 and 10 (0 = no pain, 10 = worst pain imaginable)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026